| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |